Quest Diagnostics earnings fall but beat expectations, even as COVID-19 testing revenue drops 55%
marketwatch.com
news
2022-10-20 10:59:37

Quest Diagnostics Inc. DGX, -2.25% reported Thursday third-quarter profit and revenue that fell from a year ago but beat expectations, as base business performance rebounding in the latter part of the quarter to help offset inflationary pressure and declining COVID-19 volumes. The health diagnostics information services company's stock was still inactive in the premarket. Net income fell to $256 million, or $2.17 a share, from $505 million, or $4.02 a share, in the year-ago period. Excluding nonrecurring items, adjusted earnings per share fell 40.
